The tariff classification, country of origin marking, and status under the United States-Australia Free Trade Agreement (UAFTA), of Influenza Virus Vaccine from Australia.
Reasoning
The tariff classification, country of origin marking, and status under the United States-Australia Free Trade Agreement (UAFTA), of Influenza Virus Vaccine from Australia.
Cite this ruling
CBP Ruling N165820 (3002200000): The tariff classification, country of origin marking, and status under the United States-Australia Free Trade Agreement (UAFTA), of Influenza Virus Vaccine from Australia.
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300220
The tariff classification of Infanrix (Diptheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) from Belgium
The tariff classification of Havrix (Hepatitis A Vaccine, Inactivated) from Belgium
The tariff classification of Engerix-B [Hepatitis B Vaccine (Recombinant)] from Belgium
The tariff classification of Freeze Dried BCG Vaccine and Freeze Dried Tuberculin, Purified Protein Derivative (PPD) from Japan
The tariff classification of Finished Vaccine Concentrates from France